GutMagnific® (ImmuneBiotech Medical Sweden AB, Org 556939-2813). Dr. Shahram Lavasani CEO/CSO, Dr. Mehrnaz Nouri R&D. Based at Medicon Village, Lund, Sweden. Targets IBS, ME/CFS, SIBO, Leaky Gut and Histamine Intolerance. VC-backed Jan 2021. EBITDA -8M SEK, 84.2% solidity.